PREDICT Initiative
Bringing together researchers and clinicians to advance cancer prevention and early detection, identifying cancer at its earliest and most treatable stages to improve patient outcomes.
LEARN MORE ABOUT PREDICTGroundbreaking advances in molecular science, imaging and artificial intelligence are making it possible to detect cancer at its earliest stages, often before symptoms even appear.
The PREDICT Initiative (Prevention, Risk Assessment, Early Detection and Interception of Cancer through Technology) is here to meet this moment: bringing world-class clinical care together with innovative research in molecular science, data science, and AI, moving discoveries from the lab to real-world patient care.
Early Detection Saves Lives
40% of people will be diagnosed with cancer in their lifetime
Nearly 50% of cancers are found at later stages
Many cancers can be prevented
Message from the Director
We now have the scientific tools to see cancer earlier than ever before, sometimes years before a tumor would show up on a scan. That's not a distant possibility. It's happening in labs and clinics today. Our job through the PREDICT Initiative is to take that science and put it directly into the hands of physicians and patients, as fast and as responsibly as we can.
Featured Stories
Team Led by UC San Diego Researchers Selected for Prestigious Global Cancer Prize
With up to $25 million from Cancer Grand Challenges, an international team led by UC San Diego professor Ludmil Alexandrov will unlock the secrets of DNA's "fingerprints."
How Early Detection Through PRECEDE Changed One Patient’s Future
Through the PRECEDE Consortium and the expertise of the multidisciplinary pancreatic cancer team, high-grade dysplasia, the earliest possible stage of pancreatic cancer, was identified and treated before invasive cancer could develop. Today, she remains cancer-free.
Moores Cancer Center Launches AI and Precision Oncology Fellowship with Illumina Support
Moores Cancer Center at the University of California San Diego, with support from the Illumina Corporate Foundation, has launched the inaugural Illumina/Moores Cancer Center Fellowship in Artificial Intelligence (AI) and Precision Oncology.
Giving
Generous support helps PREDICT accelerate innovative approaches to cancer prevention, early detection and intervention. Your gift can help move promising discoveries forward and give more people the opportunity for earlier detection and better outcomes.
